Fludarabine Phosphate Patent Expiration

Fludarabine Phosphate is Used for treating patients with B-cell chronic lymphocytic leukemia (CLL). It was first introduced by Genzyme Corp in its drug Fludara on Apr 18, 1991. Other drugs containing Fludarabine Phosphate are Fludarabine Phosphate, Oforta. 11 different companies have introduced drugs containing Fludarabine Phosphate.


Fludarabine Phosphate Patents

Given below is the list of patents protecting Fludarabine Phosphate, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Oforta US7148207 Oral fludara of high-purity formulation with quick release of active ingredient Dec 20, 2022

(Expired)

Sanofi Aventis Us
Oforta US7547776 Process for the production of fludarabine-phosphate lithium, sodium, potassium, calcium and magnesium salts and purification process for the production of fludarabine-phosphate and fludarabine-phosphate with a purity of at least 99.5% Dec 10, 2018

(Expired)

Sanofi Aventis Us



Fludarabine Phosphate's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Fludarabine Phosphate Generic API Manufacturers

Several generic applications have been filed for Fludarabine Phosphate. The first generic version for Fludarabine Phosphate was by Hikma Pharmaceuticals Usa Inc and was approved on Aug 28, 2003. And the latest generic version is by Actavis Llc and was approved on Feb 28, 2017.

Given below is the list of companies who have filed for Fludarabine Phosphate generic, along with the locations of their manufacturing plants worldwide.


1. ACTAVIS LLC

Actavis Llc has filed for 1 generic for Fludarabine Phosphate. Given below are the details of the strengths of this generic introduced by Actavis Llc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
50MG/2ML (25MG/ML)

injectable Discontinued INJECTION N/A Feb 28, 2017


Manufacturing Plant Locations
New

Actavis Llc's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Actavis Llc as present at those locations.

Country City Firm Name
United States
Edison Actavis LLC





2. ACTAVIS TOTOWA

Actavis Totowa Llc has filed for 1 generic for Fludarabine Phosphate. Given below are the details of the strengths of this generic introduced by Actavis Totowa.

Strength Dosage Form Availability Application Pathway TE code Launch Date
50MG/VIAL

(reference standard)

injectable Prescription INJECTION AP Feb 11, 2009


Manufacturing Plant Locations
New

Actavis Totowa's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Actavis Totowa as present at those locations.

Country City Firm Name
United States
Totowa Actavis Totowa LLC
Little Falls Actavis Totowa LLC





3. AREVA PHARMS

Areva Pharmaceuticals Inc has filed for 1 generic for Fludarabine Phosphate. Given below are the details of the strengths of this generic introduced by Areva Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
50MG/2ML (25MG/ML)

injectable Prescription INJECTION AP1 Sep 27, 2010





4. FRESENIUS KABI USA

Fresenius Kabi Usa Llc has filed for 2 different strengths of generic version for Fludarabine Phosphate. Given below are the details of the strengths of this generic introduced by Fresenius Kabi Usa.

Strength Dosage Form Availability Application Pathway TE code Launch Date
50MG/2ML (25MG/ML)

injectable Prescription INJECTION AP1 Oct 15, 2007
50MG/VIAL

injectable Prescription INJECTION AP Oct 15, 2007


Manufacturing Plant Locations
New

Fresenius Kabi Usa's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Fresenius Kabi Usa as present at those locations.

Country City Firm Name
United States
Melrose Park Fresenius Kabi USA, LLC
Wilson Fresenius Kabi USA, LLC
Skokie Fresenius Kabi USA LLC
Grand Island Fresenius Kabi USA, LLC
North Andover Fresenius Kabi USA, LLC
Bensenville Fresenius Kabi USA LLC (FK USA)
Melrose Park Fresenius Kabi USA LLC
Lake Zurich Fresenius Kabi USA, LLC





5. HIKMA

Hikma Pharmaceuticals Usa Inc has filed for 1 generic for Fludarabine Phosphate. Given below are the details of the strengths of this generic introduced by Hikma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
50MG/VIAL

injectable Prescription INJECTION AP Aug 28, 2003


Manufacturing Plant Locations
New

Hikma's manufacturing plants are situated in 3 countries - United States, Portugal, Jordan. Given below are the details of these plant locations as well as the firm names of Hikma as present at those locations.

Country City Firm Name
United States
Eatontown Hikma Pharmaceuticals USA, Inc.
Cherry Hill Hikma Pharmaceuticals USA Inc.
Dayton Hikma Injectables USA Inc
Carlsbad Hikma Cali Inc. DBA Leucadia Pharmaceuticals
Portugal
Terrugem Snt Hikma Farmaceutica, (Portugal) S.A.
Jordan
Amman Hikma Pharmaceuticals LLC





6. HOSPIRA

Hospira Worldwide, Inc has filed for 1 generic for Fludarabine Phosphate. Given below are the details of the strengths of this generic introduced by Hospira.

Strength Dosage Form Availability Application Pathway TE code Launch Date
50MG/VIAL

injectable Discontinued INJECTION N/A Apr 6, 2007


Manufacturing Plant Locations
New

Hospira's manufacturing plants are situated in 3 countries - Australia, United States, Dominican Republic (the). Given below are the details of these plant locations as well as the firm names of Hospira as present at those locations.

Country City Firm Name
Australia
Mulgrave Hospira Australia Pty Ltd.
United States
Rocky Mount Hospira, Inc.
Clayton Hospira, Inc.
Morgan Hill Hospira Inc
Mcpherson Hospira, Inc., A Pfizer Company
Lake Forest Hospira Inc
Pleasant Prairie Hospira Worldwide, LLC d.b.a. Hospira, a Pfizer-owned Company
Dominican Republic (the)
Haina, San Cristobal Hospira, Ltd.





7. RISING

Rising Pharma Holdings Inc has filed for 2 different strengths of generic version for Fludarabine Phosphate. Given below are the details of the strengths of this generic introduced by Rising.

Strength Dosage Form Availability Application Pathway TE code Launch Date
50MG/2ML (25MG/ML)

injectable Discontinued INJECTION N/A Dec 21, 2011
50MG/VIAL

injectable Discontinued INJECTION N/A Oct 16, 2012


Manufacturing Plant Locations
New

Rising's manufacturing plants are situated in 3 countries - United States, Mexico, India. Given below are the details of these plant locations as well as the firm names of Rising as present at those locations.

Country City Firm Name
United States
Flagstaff Rising High Enterprises, LLC (DBA RisingHy)
Rising Sun Rising Sun Veterinary Clinic
Fort Bragg Rising Tide Sea Vegetables
Mount Morris Rising Creek Bakery LLC
Decatur Rising Pharma Holdings, Inc
Saddle Brook Rising Pharmaceuticals, Inc.
East Brunswick Rising Pharma Holding, Inc.
Livingston Risingsun Iodine Products Corp.
Phoenix Rising Sun Farms Inc
Mexico
Pueblo San Clemente RISING FARMS SAPI DE CV
India
Ahmedabad Rising Retina Clinic





8. SAGENT PHARMS INC

Sagent Pharmaceuticals Inc has filed for 1 generic for Fludarabine Phosphate. Given below are the details of the strengths of this generic introduced by Sagent Pharms Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
50MG/2ML (25MG/ML)

injectable Prescription INJECTION AP1 Apr 28, 2004